Related Experiment Videos
Endoscopic techniques and complications in variceal sclerotherapy
1Gastroenterology Section, Veterans Administration Medical Center, Phoenix, Arizona 85012.
Journal of Clinical Gastroenterology
|October 1, 1987
Summary
Esophageal variceal sclerotherapy (EVS) effectively controls bleeding and prevents rebleeding in patients with esophageal varices. Its impact on survival depends on liver disease severity, obliteration success, and treatment complications.
Area of Science:
- Gastroenterology
- Endoscopy
- Hepatology
Background:
- Esophageal varices are a serious complication of portal hypertension.
- Esophageal variceal sclerotherapy (EVS) is a widely discussed endoscopic treatment.
- There is ongoing debate regarding EVS efficacy and safety.
Purpose of the Study:
- To review current controversies surrounding EVS.
- To offer technical suggestions for improving EVS efficacy.
- To reduce EVS-related morbidity and mortality.
Main Methods:
- Review of recent literature on esophageal variceal sclerotherapy.
- Analysis of factors influencing EVS outcomes.
- Discussion of technical aspects and complications.
Main Results:
- EVS can control active variceal hemorrhage and prevent rebleeding in stabilized patients.
- Patient survival is influenced by liver disease, obliteration success, and treatment complications.
- Prophylactic EVS may benefit selected patients.
Conclusions:
- EVS is a valuable tool for managing bleeding esophageal varices.
- Optimizing technique and patient selection can improve outcomes.
- Further research is needed to clarify EVS's role in specific patient populations.